Abstract
Background/Purpose: The liver has a remarkable capacity to regenerate after injury or resection. The aim of this review is to outline the mechanisms and factors affecting liver regeneration after liver transplantation. Methods: Relevant studies were reviewed using Medline, PubMed and Springer databases. Results: A variety of cytokines (such as interleukin-6 and tumor necrosis factor-α), growth factors (like hepatocyte growth factor and transforming growth factor-α) and cells are involved in liver regeneration. Several factors affect liver regeneration after transplantation such as ischemic injury, graft size, immunosuppression, steatosis, donor age and viral hepatitis. Conclusion: Liver regeneration has been studied for many years. However, further research is essential to reveal the complex processes affecting liver regeneration, which may provide novel strategies in the management of liver transplantation recipients and donors.
References
1.
Saxema R, Zucker SD, Crawford JM: Anatomy and physiology of the liver; in Zakim DZ, Boyer TD (eds): Hepatology: A Textbook of Liver Disease, ed 4. Philadelphia, Saunders, 2003, pp 3–30.
2.
Taub R: Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836–847.
3.
Minuk GY: Hepatic regeneration: if it ain’t broke, don’t fix it. Can J Gastroenterol 2003;17:418–424.
4.
Higgins GM, Anderson RM: Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186–202.
5.
Moser MJ, Gong Y, Zhang MN, Johnston J, Lipschitz J, Minuk GY: Immediate-early protooncogene expression and liver function following various extents of partial hepatectomy in the rat. Dig Dis Sci 2001;46:907–914.
6.
Fausto N: Liver regeneration: from laboratory to clinic. Liver Transpl 2001;7:835–844.
7.
Olthoff KM: Hepatic regeneration in living donor liver transplantation. Liver Transpl 2003;9:S35–S41.
8.
Debonera F, Aldeguer X, Shen X, Gelman AE, Gao F, Que X, Greenbaum LE, Furth EE, Taub R, Olthoff KM: Activation of interleukin-6/STAT3 and liver regeneration after transplantation. J Surg Res 2001;96:289–295.
9.
Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60–66.
10.
Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL: Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991;66:245–256.
11.
Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M, Grompe M: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996;12:266–273.
12.
Fausto N, Campbell JS: The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003;120:117–130.
13.
Chattopadhyay P, Wahi AK, Agrawal SS: Organogenesis and regeneration of liver: mechanism and signal cascade. Asian J Biochem 2007;2:364–374.
14.
Grisham JW: A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver: autoradiography with thymidine-H. Cancer Res 1962;22:842–849.
15.
Bucher NLR: Regeneration of mammalian liver. Int Rev Cytol 1963;15:245–300.
16.
Sell S: Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001;33:738–750.
17.
Shafritz DA, Dabeva MD: Liver stem cells and model systems for liver repopulation. J Hepatol 2002;36:552–564.
18.
Kandilis AN, Koskinas J, Tiniakos DG, Nikiteas N, Perrea DN: Liver regeneration: focus on cell types and topographic differences. Eur Surg Res 2010;44:1–12.
19.
Vassilopoulos G, Wang PR, Russell DW: Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;922:901–904.
20.
Duncan AW, Dorrell C, Grompe M: Stem cells and liver regeneration. Gastroenterology 2009;137:466–481.
21.
Olthoff KM: Liver regeneration: clinical relevance; in Blumgart LH (ed): Surgery of the Liver, Biliary Tract and Pancreas, ed 4. Philadelphia, Saunders, 2007, pp 54–62.
22.
Chattopadhyay P, Agrawal SS, Garg A: Triiodothyronine (T3) regulation of liver cell regeneration in alcohol-induced liver cell injury in partially hepatoctomised albino rats. Ind J Gastroentrol 2006;25:165–166.
23.
Chattopadhyay P, Garg A, Varshney VP, Shama AK, Agarawal SS: Increase insulin activity by Phyllanthus amarus Linn on liver regeneration in partially hepatoctomised albino rats. Res J Med Plant 2007;1:17–20.
24.
Taub R: Hepatic regeneration; in Zakim DZ, Boyer TD (eds): Hepatology: A Textbook of Liver Disease, ed 4. Philadelphia, Saunders, 2003, pp 31–48.
25.
Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA: Liver regeneration. J Am Coll Surg 2003;197:634–359.
26.
Michalopoulos GK: Liver regeneration. J Cell Physiol 2007;213:286–300.
27.
Webber EM, Bruix J, Pierce RH, Fausto N: Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998;28:1226–1234.
28.
Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM: Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579–G585.
29.
Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP: Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996;110:1854–1862.
30.
Iwai M, Cui TX, Kitamura H, Saito M, Shimazu T: Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy. Cytokine 2001;13:60–64.
31.
Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379–1383.
32.
Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441–1446.
33.
Beg AA: Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002;23:509–512.
34.
Cornell RP, Lilijequist BL, Bartizal KF: Depressed liver regeneration after partial hepatectomy in germ-free athymic and lipopolysaccharide-resistant mice. Hepatology 1990;11:916–922.
35.
Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, Lambris JD: The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003;198:913–923.
36.
LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL: An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. J Clin Invest 1991;87:39–44.
37.
Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK: Changes in WNT/betacatenin pathway during regulated growth in rat liver regeneration. Hepatology 2001;33:1098–1109.
38.
Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK: Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 2004;39:1056–1065.
39.
Taub R, Greenbaum L, Peng Y: Transcriptional regulatory signals define cytokine dependent and independent pathways in liver regeneration. Semin Liver Dis 1999;19:117–127.
40.
Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ: Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999;29:403–411.
41.
Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, Zamir GA, Hiroyasu S, Kovalovich KK, Taub R, Olthoff KM: Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002;35:40–48.
42.
Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Müller W, Trautwein C: Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003;278:11281–11288.
43.
Cressman DE, Diamond RH, Taub R: Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 1995;21:1443–1449.
44.
FitzGerald MJ, Webber EM, Donovan JR, Fausto N: Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995;6:417–427.
45.
DeAngelis RA, Kovalovich K, Cressman DE, Taub R: Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 2001;33:915–924.
46.
Li W, Liang X, Kellendonk C, Poli V, Taub R: STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411–28417.
47.
Hayashi H, Nagaki M, Imose M, Osawa Y, Kimura K, Takai S, Imao M, Naiki T, Kato T, Moriwaki H: Normal liver regeneration and liver cell apoptosis after partial hepatectomy in tumor necrosis factor-alpha-deficient mice. Liver Int 2005;25:162–170.
48.
Fujita J, Marino MW, Wada H, Jungbluth AA, Mackrell PJ, Rivadeneira DE, Stapleton PP, Daly JM: Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 2001;129:48–54.
49.
Fausto N, Campbell JS, Riehle KJ: Liver regeneration. Hepatology 2006;43:S45–S53.
50.
Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, Heinrich PC, Fausto N: Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2001;107:1285–1292.
51.
Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK: The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688–693.
52.
Currier AR, Sabla G, Locaputo S, et al: Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. Am J Physiol Gastrointest Liver Physiol 2003;284:G508–G515.
53.
Okano J, Shiota G, Matsumoto K, Yasui S, Kurimasa A, Hisatome I, Steinberg P, Murawaki Y: Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 2003;309:298–304.
54.
Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C: Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 2004;101:10608–10613.
55.
Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM: Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991;6:501–504.
56.
Burr A, Toole K, Chapman C, Hines JE, Burt AD: Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J Pathol 1998;185:298–302.
57.
Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA, Thorgeirsson SS: Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004;101:4477–4482.
58.
Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699–702.
59.
Dietrich S, Abou-Rebyeh F, Brohmann H, Bladt F, Sonnenberg-Riethmacher E, Yamaai T, Lumsden A, Brand-Saberi B, Birchmeier C: The role of SF/HGF and c-Met in the development of skeletal muscle. Development 1999;126:1621–1629.
60.
Bucher NL, Patel U, Cohen S: Hormonal factors concerned with liver regeneration. Ciba Found Symp 1977;55:95–107.
61.
Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E: Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988;8:992–996.
62.
Olsen PS, Poulsen SS, Kirkegaard P: Adrenergic effects on secretion of epidermal growth factor from Brunner’s glands. Gut 1985;26:920–927.
63.
Cruise JL, Houck KA, Michalopoulos GK: Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 1985;227:749–751.
64.
Houck KA, Cruise JL, Michalopoulos G: Norepinephrine modulates the growth inhibitory effect of transforming growth factor-beta in primary rat hepatocyte cultures. J Cell Physiol 1988;135:551–555.
65.
Mead JE, Fausto N: Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989;86:1558–1562.
66.
Webber EM, Wu JC, Wang L, Merlino G, Fausto N: Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994;145:398–408.
67.
Russell WE, Kaufmann WK, Sitaric S, Leutteke NC, Lee DC: Liver regeneration and hepatocarcinogenesis in transforming growth factor alpha-targeted mice. Mol Carcinog 1996;15:183–189.
68.
Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y, Umeki S, Ito N, Yamada A, Miyagawa J, Higashiyama S, Iwawaki T, Saito M, Taniguchi N, Matsuzawa Y, Kohno K: Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 2003;124:701–707.
69.
Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, Fausto N: Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005;280:2562–2568.
70.
Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA: Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology 2005;128:424–432.
71.
LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N: Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890–893.
72.
Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, Brenner DA: c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003;37:824–832.
73.
Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, Loyer P, Guguen-Guillouzo C, Baffet G: The mitogen-activated protein kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003–6011.
74.
Behrens A, Sibilia M, David JP, Möhle-Steinlein U, Tronche F, Schütz G, Wagner EF: Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2002;21:1782–1790.
75.
Peters M, Blinn G, Jostock T, Schirmacher P, Meyer zum Büschenfelde KH, Galle PR, Rose-John S: Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 2000;119:1663–1671.
76.
Leu JI, Crissey MAS, Leu JP, Ciliberto G, Taub R: Interleukin-6-induced Stat3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 2001;21:414–424.
77.
Weir E, Chen Q, Defrances MC, Bell A, Taub R, Zarnegar R: Rapid induction of mRNAs for liver regeneration factor (LRF-1) and insulin-like growth factor binding protein-1 (IGFBP-1) in primary cultures of rat hepatocytes by hepatocyte growth factor and epidermal growth factor. Hepatology 1994;20:955–960.
78.
Kim TH, Mars WM, Stolz DB, Michalopoulos GK: Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 2000;31:75–82.
79.
Argast GM, Campbell JS, Brooling JT, Fausto N: Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem 2004;279:34530–34536.
80.
Lee DC, Sunnarborg SW, Hinkle CL, Myers TJ, Stevenson MY, Russell WE, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Chang A, Jackson LF: TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann NY Acad Sci 2003;995:22–38.
81.
Jonge J, Olthoff KM: Liver regeneration; in Gruessner RWG, Benedetti E (eds): Living Donor Organ Transplantation, ed 1. New York, McGraw-Hill, 2008, pp 459–467.
82.
Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577–584.
83.
Houck KA, Michalopoulos GK: Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J Cell Physiol 1989;141:503–509.
84.
Gohda E, Matsunaga T, Kataoka H, Yamamoto I: TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep 1992;16:917–926.
85.
Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK: Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res 1996;56:2837–2843.
86.
Rana B, Mischoulon D, Xie Y, Bucher NL, Farmer SR: Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Mol Cell Biol 1994;14:5858–5869.
87.
Gkretsi V, Bowen WC, Yang Y, Wu C, Michalopoulos GK: Integrin-linked kinase is involved in matrix-induced hepatocyte differentiation. Biochem Biophys Res Commun 2007;353:638–643.
88.
Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, Yang Y, Yu YP, Orr A, St-Arnaud R, Dedhar S, Kaestner KH, Wu C, Michalopoulos GK: Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology 2008;48:1932–1941.
89.
Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, Orr A, Monga SP, Wu C, Michalopoulos GK: Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009;50:844–851.
90.
Date M, Matsuzaki K, Matsushita M, Tahashi Y, Sakitani K, Inoue K: Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol 2000;32:251–260.
91.
Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H: Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 2001;33:569–576.
92.
Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007;130:1120–1133.
93.
Selzner M, Camargo CA, Clavien PA: Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999;30:469–475.
94.
Olthoff KM: Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002;26:831–837.
95.
Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843–852.
96.
Debonera F, Que X, Aldeguer X, Abt P, Gelman AE, Shaked A, Olthoff KM: Partial liver grafts with prolonged cold preservation initiate blunted regenerative responses (abstract). Am J Transplant 2002;2:156.
97.
Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC: Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005;242:314–325.
98.
Francavilla A, Zeng Q, Polimeno L: Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology 1994;19:210–216.
99.
Kiuchi T, Kashahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K: Impact of graft size mismatching on graft prognosis in liver transplantation from living donor. Transplantation 1999;67:321–327.
100.
Lo CM, Fan ST, Liu CL, Chan JK, Lam BK, Lau GK, Wei WI, Wong J: Minimum graft size for successful living donor liver transplantation. Transplantation 1999;68:1112–1116.
101.
Selzner N, Selzner M, Tian Y, Kadry Z, Clavien PA: Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-α/IL-6-dependent mechanism. Hepatology 2002;36:812–818.
102.
Uchiyama H, Yanaga K, Nishizaki T, Soejima Y, Yoshizumi T, Sugimachi K: Effects of deletion variant of hepatocyte growth factor on reduced-size liver transplantation in rats. Transplantation 1999;68:39–44.
103.
Malik R, Habib M, Tootle R, Hodgson H: Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential – a study relevant to donor preconditioning. Am J Transplant 2005;5:1801–1807.
104.
Columbano A, Simbula M, Pibiri M, Perra A, Deidda M, Locker J, Pisanu A, Uccheddu A, Ledda-Columbano GM: Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration. Cell Prolif 2008;41:521–531.
105.
Taki-Eldin A, Zhou L, Xie HY, Chen KJ, Zhou WH, Zhang W, Xing CY, Yang Z, Zhang K, Zheng SS: Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats. J Hepatobiliary Pancreat Sci 2011;18:806–814.
106.
Tamasi V, Kiss A, Dobozy O, Falus A, Vereczkey L, Monostory K: The effect of dexamethasone on p 450 activities in regenerating rat liver. Biochem Biophys Res Commun 2001;286:239–242.
107.
Debonera F, Krasinkas A, Gelman A, Aldeguer X, Que X, Shaked A, Olthoff KM: Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology 2003;38:1563–1572.
108.
Mazzaferro V, Porter KA, Scotti-Foglieni CL, Venkataramanan R, Makowka L, Rossaro L, Francavilla A, Todo S, Van Thiel DH, Starzl TE: The hepatotropic influence of cyclosporine. Surgery 1990;107:533–539.
109.
Starzl TE, Porter KA, Mazzaferro V, Todo S, Fung J, Francavilla A: Hepatotrophic effects of FK506 in dogs. Transplantation 1991;51:67–69.
110.
Francavilla A, Carr BI, Starzl TE, Azzarone A, Carrieri G, Zeng QH: Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology 1992;15:871–877.
111.
Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT: Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Liver Transpl 2002;8:212–218.
112.
Selzner M, Clavien PA: Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000;31:35–42.
113.
Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM: Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease patho-physiology. Hepatology 2001;34:694–706.
114.
Farrel GC: Drugs and steatohepatitis. Semin Liver Dis 2002;22:185–194.
115.
Kurumiya Y, Nozawa K, Sakaguchi K, Nagino M, Nimura Y, Yoshida S: Differential suppression of liver-specific genes in regenerating rat liver induced by extended hepatectomy. J Hepatol 2000;32:636–644.
116.
Behrns KE, Tsiotos GG, DeSouza NE, Krishna MK, Ludwig J, Nagorney DM: Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292–298.
117.
Selzner M, Clavien PA: Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105–113.
118.
Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Stewart G, McCaughan G: Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500–505.
119.
Urena MA, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno Sanz C: An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology 1999;46:1164–1173.
120.
Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Fulcher AS, Posner MP: Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375–1379.
121.
Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA: Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004;40:1322–1332.
122.
Farrell GC: Probing Prometheus: fat fueling the fire? Hepatology 2004;40:1252–1255.
123.
Taguchi T, Fukuda M, Ohashi M: Differences in DNA synthesis in vitro using isolated nuclei from regenerating livers of young and aged rats. Mech Ageing Dev 2001;122:141–155.
124.
Ikegami T, Nishizaki T, Yanaga K, Shimada M, Kishikawa K, Nomoto K, Uchiyama H, Sugimachi K: The impact of donor age on living donor liver transplantation. Transplantation 2000;70:1703–1707.
125.
Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A: Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004;4:1302–1307.
126.
Gaglio PJ, Malireddy S, Levitt BS, Lapointe-Rudow D, Lefkowitch J, Kinkhabwala M, Russo MW, Emond JC, Brown RS Jr: Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003;9:1028–1035.
127.
Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-Valdecasas JC, Rimola A: Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004;40:699–707.
128.
Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R: Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004;10:340–346.
129.
Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA: Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004;10:1248–1255.
130.
Humar A, Horn K, Kalis A, Glessing B, Payne WD, Lake J: Living donor and split-liver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence? Am J Transplant 2005;5:399–405.
131.
Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P: Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000;20:47–55.
132.
Erhardt A, Hassan M, Heintges T, Häussinger D: Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002;292:272–284.
133.
Lee MN, Jung EY, Kwun HJ, Jun HK, Yu DY, Choi YH, Jang KL: Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-β pathway. J Gen Virol 2002;83:2145–2151.
134.
Michalopoulos GK: Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2–13.
135.
Fausto N, Riehle KJ: Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg 2005;12:181–189.
136.
Nadalin S, Testa G, Malago M, Beste M, Frilling A, Schroeder T, Jochum C, Gerken G, Broelsch CE: Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 2004;10:1024–1029.
137.
Humar A, Kosari K, Sielaff TD, Glessing B, Gomes M, Dietz C, Rosen G, Lake J, Payne WD: Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl 2004;10:374–378.
138.
Haga J, Shimazu M, Wakabayashi G, Tanabe M, Kawachi S, Fuchimoto Y, Hoshino K, Morikawa Y, Kitajima M, Kitagawa Y: Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl 2008;14:1718–1724.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
